Literature DB >> 25207704

Profile of ocular and adnexal tumours at a tertiary institute of northeast India.

Dipankar Das1, Panna Deka, Varsha Ramachandra, Kasturi Bhattacharjee, Jayanta Kumar Das, Ganesh Chandra Kuri, Prerana S Tahiliani, Pankaj Bhattacharyya, Harsha Bhattacharjee, Rajashree Paul, Apurba Deka.   

Abstract

PURPOSE: To present the profile of patients with ocular and adnexal tumours presenting at a tertiary eye care institute in northeast India in ten years between 2003 and 2013.
DESIGN: Hospital based retrospective review of medical records.
METHOD: The clinical history, site of involvement and pathological diagnoses were retrieved from ocular pathology registers from October 2003-October 2013. This included conjunctival, orbital, adnexal and intraocular tumours. All specimens were fixed, processed and stained. Immunohistochemistry was carried out where ever indicated to come to a final diagnosis.
RESULTS: In all 1003 cases were included in our study, with 622 (62.01%) benign tumours and 381 (37.98%) malignant tumours. 54.63% were males and 45.36% were females. Amongst the conjunctival tumours, squamous cell carcinoma (SCC) (72.5%) and nevus (39.6%) were the most common malignant and benign tumour, respectively. Non-Hodgkin's lymphoma (NHL) (60%) was the most common malignant orbital tumour. Retinoblastoma (RB) (81.5%) was the most common intraocular malignancy, followed by melanoma (18.4%). Basal cell carcinoma (BCC) (35.1%) was the most common malignancy in the lid.
CONCLUSION: NHL and SCC were the most frequently seen malignant tumours in adults while RB was the most common intraocular tumour in children.

Entities:  

Keywords:  Non-Hodgkin’s lymphoma; retinoblastoma; squamous cell carcinoma; tumours

Mesh:

Year:  2014        PMID: 25207704     DOI: 10.3109/01676830.2014.949789

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  1 in total

1.  Immunohistochemistry on pattern of ocular & adnexal tumours in a tertiary eye care centre of Northeast India.

Authors:  Dipankar Das; Harsha Bhattacharjee; Apurba Deka; Panna Deka; Samir Serasiya; Kasturi Bhattacharjee; Jayanta Kumar Das; Ganesh Chandra Kuri; Eknath Pawar; Rushil Kumar Saxena
Journal:  Indian J Med Res       Date:  2018-01       Impact factor: 2.375

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.